MedPath

Investigation of the efficacy of lyophilized prepuce on urinary reflux

Phase 2
Conditions
Vesicoureteral reflux.
Vesicoureteral-reflux-associated uropathy
Registration Number
IRCT2016062628641N1
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Male
Target Recruitment
80
Inclusion Criteria

Vesicoureteral reflux grade 2-5 based on clinical and paraclinical evidence; Having the indication for stretching material endoscopic injection.
Exclusion criteria: Having deflux contraindications based on the protocols announced by the deflux producer; Having the indication for stretching material endoscopic injection; Having prohibition of operation according to consultation with anesthesiologist and heart expert; Children with 1st grade reflux grade 1 and recurrent or febrile urinary tract infection

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
rinary Tract Infection. Timepoint: 3, 6, and 9 months after intervention. Method of measurement: Urinary culture.;The rate of urine rejection (return) from the bladder to the ureter. Timepoint: Before and 3, 6, and 9 months after intervention. Method of measurement: VCUG.
Secondary Outcome Measures
NameTimeMethod
-. Timepoint: -. Method of measurement: -.
© Copyright 2025. All Rights Reserved by MedPath